NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.8650
-0.0130 (-1.48%)
Jun 23, 2026, 5:35 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €10.96 million as of June 23, 2026. Its market cap has decreased by -25.17% in one year.
Market Cap
10.96M
Enterprise Value
9.34M
Revenue
188.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 10.96M, a decrease of -43.71%. That is a compound annual growth rate of -10.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 10.96M | -26.57% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | 19.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 34.02M |
| genOway Société anonyme | 21.67M |
| GenSight Biologics | 20.09M |
| Advicenne | 15.83M |
| Aelis Farma | 13.60M |
| Poxel | 11.18M |
| Aton | 9.11M |
| TME Pharma | 6.90M |